Active Ingredient(s): Oritavancin Diphosphate
FDA Approved: * March 12, 2021
Pharm Company: * MELINTA THERAP
Category: Antibiotics

Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin.[4] The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved oritavancin for treatment of acute bacterial skin and skin structure infections.[5][3] Conten... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Kimyrsa 1200 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 70842-225
Melinta Therapeutics, LLC

Related Brands

Drugs with the same active ingredients